New opportunity for cancer drug development
(PHYSorg.com Medicine & Health)

After years of research on cell surface receptors called Frizzleds, researchers at Karolinska Institutet in Sweden provide the proof-of-principle that these receptors are druggable by small molecules. The results, which are published in the scientific journal Nature Communications, open the way for new strategies to treat different types of cancer.